1,4-Dioxaspiro[4.5]decan-8-one → [5-(8-Hydroxy-1,4-dioxa-spiro[4.5]dec-8-yl)-thiazol-2-yl]-carbamic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6](=[O:13])[NH:7][C:8]1[S:9][CH:10]=[CH:11][N:12]=1)([CH3:4])([CH3:3])[CH3:2].[O:14]1[C:18]2([CH2:23][CH2:22][C:21](=[O:24])[CH2:20][CH2:19]2)[O:17][CH2:16][CH2:15]1>>[C:1]([O:5][C:6](=[O:13])[NH:7][C:8]1[S:9][C:10]([C:21]2([OH:24])[CH2:22][CH2:23][C:18]3([O:17][CH2:16][CH2:15][O:14]3)[CH2:19][CH2:20]2)=[CH:11][N:12]=1)([CH3:4])([CH3:2])[CH3:3]Participants
3
Procedure
The title compound was prepared as a white solid from thiazol-2-yl-carbamic acid tert-butyl ester (prepared according to Das, B. et al. Tetrahedron Lett. 2006, 47, 7551-7556) and 1,4-dioxa-spiro[4.5]decan-8-one using the procedure described in Step A of Example 33.
Sources & evidence
- ORD record
- ord-f2a265af29ae4d268b59b66eb2d2b0e3
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450304B2
Reaction notes
Loading…